...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Isolation of human CD4/CD8 double-positive, graft-versus-host disease-protective, minor histocompatibility antigen-specific regulatory T cells and of a novel HLA-DR7-restricted HY-specific CD4 clone
【24h】

Isolation of human CD4/CD8 double-positive, graft-versus-host disease-protective, minor histocompatibility antigen-specific regulatory T cells and of a novel HLA-DR7-restricted HY-specific CD4 clone

机译:分离人CD4 / CD8双阳性,移植物抗宿主疾病的保护性次要组织相容性抗原特异性调节性T细胞和新型HLA-DR7限制性HY特异性CD4克隆

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Minor histocompatibility (H) Ags are classically described as self-peptides derived from intracellular proteins that are expressed at the cell surface by MHC class I and class II molecules and that induce T cell alloresponses. We have isolated three different T cell populations from a skin biopsy of a patient suffering from acute graft-versus-host disease following sex-mismatched HLAidentical bone marrow transplantation. The first population was: 1) CD4 +/CD8+ double-positive; 2) specific for an HLA class I- restricted autosomal Ag; 3) expressed a Tr1 profile with high levels of IL-10, but low IL-2 and IFN-γ; and 4) exerted regulatory function in the presence of recipient APCs. The second was CD8 positive, specific for an HLA class I-restricted autosomally encoded minor H Ag, but was only weakly cytotoxic. The third was CD4 single positive, specific for an HLA-DR7-restricted HY epitope and exerted both proliferative and cytotoxic functions. Identification of the peptide recognized by these latter cells revealed a new human HY epitope, TGKIINFIKFDTGNL, encoded by RPS4Y and restricted by HLA-DR7. In this paper, we show human CD4/CD8 double-positive, acute graft-versus-host disease-protective, minor H Ag-specific regulatory T cells and identify a novel HLA-DR7/ HY T cell epitope, encoded by RPS4Y, a potential new therapeutic target.
机译:次要组织相容性(H)Ags通常被描述为衍生自细胞内蛋白的自身肽,这些蛋白是由MHC I类和II类分子在细胞表面表达并诱导T细胞的过敏反应。我们从患有性别不匹配的HLA相同的骨髓移植后患有急性移植物抗宿主病的患者的皮肤活检中分离出三个不同的T细胞群。第一个人群是:1)CD4 + / CD8 +双阳性; 2)特定于HLA I类限制的常染色体Ag; 3)表达高水平的IL-10,低水平的IL-2和IFN-γ的Tr1表达。 4)在受体APC的存在下发挥调节功能。第二个是CD8阳性,特异性针对HLA I类限制的自体编码的次要HAg,但仅具有弱细胞毒性。第三个是CD4单阳性,特异性针对HLA-DR7限制的HY表位,并具有增殖和细胞毒性功能。这些后来的细胞识别的肽的鉴定揭示了一个新的人类HY表位TGKIINFIKFDTGNL,该表位由RPS4Y编码并受HLA-DR7限制。在本文中,我们显示了人类CD4 / CD8双阳性,急性移植物抗宿主疾病的保护性,次要的H Ag特异性调节性T细胞,并鉴定了由RPS4Y编码的新型HLA-DR7 / HY T细胞表位,潜在的新治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号